Total Funding
13
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
KineMed is a biotechnology company that specializes in providing translational and personalized medicine.
David Fineman: Founder, CEO and Chairman
About the Company
KineMed is a biotechnology company that specializes in providing translational and personalized medicine. The company offers unparalleled insight into the complex biological processes underlying the root causes of disease. It uses the administration of stable (non-radioactive) isotopes to provide high-definition pharmacological measurements of
disease activity and drug effects across a wide range of therapy areas, including diseases of the nervous system, metabolic and cardiovascular diseases, cancer, inflammation, and musculoskeletal diseases.
It was founded in 2001 and headquartered in Emeryville, California.
